These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27364506)

  • 41. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
    Yang Y; Pan L; Shao Z
    Breast Cancer Res Treat; 2021 Dec; 190(3):503-515. PubMed ID: 34554371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.
    Xia C; Schroeder MC; Weigel RJ; Sugg SL; Thomas A
    Ann Surg Oncol; 2014 Dec; 21(13):4133-8. PubMed ID: 24934585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of the effect of the American Society of Breast Surgery guidelines on contralateral prophylactic mastectomy rates for unilateral breast cancer.
    Steadman JA; Hoskin TL; Klassen C; Boughey JC; Degnim AC; Piltin MA; Mrdutt MM; Johnson JE; Hieken TJ
    Surgery; 2024 Mar; 175(3):677-686. PubMed ID: 37863697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contralateral Prophylactic Mastectomy in Patients with Breast Cancer.
    Noditi A; Caragheorghe G; Stoleru S; Blidaru A; Bordea CI
    Chirurgia (Bucur); 2021; 116(2 Suppl):73-83. PubMed ID: 33963696
    [No Abstract]   [Full Text] [Related]  

  • 45. Predictors for contralateral prophylactic mastectomy in breast cancer patients.
    Fu Y; Zhuang Z; Dewing M; Apple S; Chang H
    Int J Clin Exp Pathol; 2015; 8(4):3748-64. PubMed ID: 26097557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Evaluation of the Choice for Contralateral Prophylactic Mastectomy and Patient Concerns About Recurrence in a Reconstructed Cohort.
    Sando IC; Billig JI; Ambani SW; Kraft CT; Kidwell KM; Zhong L; Chung KC; Momoh AO
    Ann Plast Surg; 2018 Apr; 80(4):333-338. PubMed ID: 29166308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are There Disparities in Breast Reconstruction After Contralateral Prophylactic Mastectomy?
    Lattimore CM; Meneveau MO; Desai R; Camacho TF; Squeo GC; Showalter SL
    J Surg Res; 2024 Jun; 298():277-290. PubMed ID: 38636184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors Affecting Choice of Treatment for Early-Stage Breast Cancer in West Virginia: A 10-Year Experience from a Rural Tertiary Care Center.
    Suggs PD; Holliday TL; Thompson SN; Richmond BK
    Am Surg; 2017 Jul; 83(7):709-716. PubMed ID: 28738940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case-control analysis.
    Wang M; Chen H; Wu K; Ding A; Zhang P; Zhang M
    Breast Cancer Res Treat; 2019 Jul; 176(2):337-347. PubMed ID: 31020469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy.
    Christian N; Zabor EC; Cassidy M; Flynn J; Morrow M; Gemignani ML
    Ann Surg Oncol; 2020 Mar; 27(3):743-749. PubMed ID: 31732944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival Outcomes in Women with Unilateral, Triple-Negative, Breast Cancer Correlated with Contralateral Prophylactic Mastectomy.
    Fasano GA; Bayard S; Chen Y; Marti J; Simmons R; Swistel A; Bensenhaver J; Davis M; Newman L
    Ann Surg Oncol; 2023 Aug; 30(8):4648-4656. PubMed ID: 36681737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer.
    Wahlen MM; Lizarraga IM; Kahl AR; Zahnd WE; Eberth JM; Overholser L; Askelson N; Hirschey R; Yeager K; Nash S; Engelbart JM; Charlton ME
    Cancer Causes Control; 2023 Dec; 34(Suppl 1):171-186. PubMed ID: 37095280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
    King TA; Sakr R; Patil S; Gurevich I; Stempel M; Sampson M; Morrow M
    J Clin Oncol; 2011 Jun; 29(16):2158-64. PubMed ID: 21464413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction.
    Koslow S; Pharmer LA; Scott AM; Stempel M; Morrow M; Pusic AL; King TA
    Ann Surg Oncol; 2013 Oct; 20(11):3422-9. PubMed ID: 23720070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benefits and risks of contralateral prophylactic mastectomy in women undergoing treatment for sporadic unilateral breast cancer: a decision analysis.
    Lester-Coll NH; Lee JM; Gogineni K; Hwang WT; Schwartz JS; Prosnitz RG
    Breast Cancer Res Treat; 2015 Jul; 152(1):217-226. PubMed ID: 26062750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trends in Contralateral Prophylactic Mastectomy.
    Fairbairn K; Cervantes A; Rayhrer C; Steen S
    Aesthetic Plast Surg; 2020 Apr; 44(2):323-329. PubMed ID: 31853610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
    Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
    Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
    Davies KR; Brewster AM; Bedrosian I; Parker PA; Crosby MA; Peterson SK; Shen Y; Volk RJ; Cantor SB
    Breast Cancer Res; 2016 Sep; 18(1):93. PubMed ID: 27650678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contralateral prophylactic mastectomy at the time of delayed microvascular breast reconstruction adversely affects patient-reported outcomes: A retrospective cohort study.
    Kerrebijn I; Retrouvey H; Härmä M; Sebastiampillai S; Zhong T; Hofer SOP; O'Neill AC
    J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):785-791. PubMed ID: 33214123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.